Top shareholders of ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q1 2019
As of 31 Mar 2019,
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
812,507 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, BlackRock Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, Tibra Equities Europe Ltd, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, NORTHERN TRUST CORP, and DEUTSCHE BANK AG\.
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
Investor
Option
Weight %
Change %
Value $
* Price
Shares
Share Change
Activity
Report Period
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
0
Q1 2019 holders
16
Holder diff
16
Investor
Q4 2018 Shares
Q1 2019 Shares
Share Diff
Share Chg %
Q4 2018 Value $
Q1 2019 Value $
Value Diff $
Value Chg %
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and, if you allow them, measure engagement and deliver
advertising. Analytics and marketing storage stay off until you grant
consent. By clicking on "Agree and continue", you declare your consent to
the use of the selected optional cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.